Life Science REIT PLC (LABS) — Financial Flexibility Index
Life Science REIT PLC (LABS) has a Financial Flexibility Index of 0.05x as of June 2025. Free cash flow of GBX6.76 Million (operating CF GBX958.00K minus capex GBX5.81 Million) represents 0% of total liabilities (GBX141.89 Million). Check LABS cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Life Science REIT PLC Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for Life Science REIT PLC across 4 annual periods. For the full cash flow conversion analysis, see LABS operating cash flow.
Annual Financial Flexibility Index for Life Science REIT PLC (2021–2024)
Year-by-year free cash flow to debt coverage for Life Science REIT PLC. Explore LABS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.23x | GBX32.20 Million | GBX12.92 Million | GBX138.42 Million | ▼ -6.7% |
| 2023 | 0.25x | GBX31.65 Million | GBX7.62 Million | GBX126.96 Million | ▲ +388.4% |
| 2022 | 0.05x | GBX6.55 Million | GBX-1.09 Million | GBX128.37 Million | ▼ -95.1% |
| 2021 | 1.03x | GBX11.18 Million | GBX3.54 Million | GBX10.82 Million | — |